Role of the PD-1/PD-L inhibitory pathway during experimental infection by Trypanosoma cruzi Tulahuen strain

to related objects

Alternative title: Rolle des PD-1/PD-L-Inhibitionswegs während der experimentellen Infektion mit dem Trypanosoma cruzi Tulahuen-Stamm

Location: Deutsche Nationalbibliothek Frankfurt am Main

Extent: Online-Ressource

Language: Englisch

Notes: Hamburg, Universität Hamburg, Dissertation, 2018

Keyword: Trypanosoma cruzi
Infection
Immune response

Event: Veröffentlichung

(where): Hamburg

(who): Staats- und Universitätsbibliothek Hamburg

(when): 2019

Creator: Arana P., Yanina Helga

Contributor: Jacobs, Thomas

URN: urn:nbn:de:gbv:18-95191

Rights: Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 10:45 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Arana P., Yanina Helga
Jacobs, Thomas
Staats- und Universitätsbibliothek Hamburg

Time of origin

2019

Other Objects (12)

PD-1/PD-L blockade in gastrointestinal cancers: lessons learned and the road toward precision immunotherapy

Clathrin expression in Trypanosoma cruzi

Combined use of tyrosine kinase inhibitors with PD-(L)1 blockade increased the risk of thyroid dysfunction in PD-(L)1 blockade: a prospective study

The PD-1/PD-L1 Inhibitory Pathway is Altered in Primary Glomerulonephritides

Plant Metabolites Active against Trypanosoma cruzi

First-line hepatic arterial infusion chemotherapy plus lenvatinib and PD-(L)1 inhibitors versus systemic chemotherapy alone or with PD-(L)1 inhibitors in unresectable intrahepatic cholangiocarcinoma

WNT/β-catenin regulatory roles on PD-(L)1 and immunotherapy responses

CTLA4 blockade abrogates KEAP1/STK11-related resistance to PD-(L)1 inhibitors

Immune response in breast cancer brain metastases and their microenvironment: the role of the PD-1/PD-L axis

Bestimmung der PD-L1-Expression auf CTCs von NSCLC-Patienten und Korrelation mit dem Therapieansprechen auf PD-(L)1-Inhibitoren

Amaryllidaceae alkaloids with anti-Trypanosoma cruzi activity

NK cell transfer overcomes resistance to PD-(L)1 therapy in aged mice

PD-1/PD-L blockade in gastrointestinal cancers: lessons learned and the road toward precision immunotherapy

Clathrin expression in Trypanosoma cruzi

Combined use of tyrosine kinase inhibitors with PD-(L)1 blockade increased the risk of thyroid dysfunction in PD-(L)1 blockade: a prospective study

The PD-1/PD-L1 Inhibitory Pathway is Altered in Primary Glomerulonephritides

Plant Metabolites Active against Trypanosoma cruzi

First-line hepatic arterial infusion chemotherapy plus lenvatinib and PD-(L)1 inhibitors versus systemic chemotherapy alone or with PD-(L)1 inhibitors in unresectable intrahepatic cholangiocarcinoma

WNT/β-catenin regulatory roles on PD-(L)1 and immunotherapy responses

CTLA4 blockade abrogates KEAP1/STK11-related resistance to PD-(L)1 inhibitors

Immune response in breast cancer brain metastases and their microenvironment: the role of the PD-1/PD-L axis

Bestimmung der PD-L1-Expression auf CTCs von NSCLC-Patienten und Korrelation mit dem Therapieansprechen auf PD-(L)1-Inhibitoren

Amaryllidaceae alkaloids with anti-Trypanosoma cruzi activity

NK cell transfer overcomes resistance to PD-(L)1 therapy in aged mice

PD-1/PD-L blockade in gastrointestinal cancers: lessons learned and the road toward precision immunotherapy

Clathrin expression in Trypanosoma cruzi

Combined use of tyrosine kinase inhibitors with PD-(L)1 blockade increased the risk of thyroid dysfunction in PD-(L)1 blockade: a prospective study

The PD-1/PD-L1 Inhibitory Pathway is Altered in Primary Glomerulonephritides

Plant Metabolites Active against Trypanosoma cruzi

First-line hepatic arterial infusion chemotherapy plus lenvatinib and PD-(L)1 inhibitors versus systemic chemotherapy alone or with PD-(L)1 inhibitors in unresectable intrahepatic cholangiocarcinoma

WNT/β-catenin regulatory roles on PD-(L)1 and immunotherapy responses

CTLA4 blockade abrogates KEAP1/STK11-related resistance to PD-(L)1 inhibitors

Immune response in breast cancer brain metastases and their microenvironment: the role of the PD-1/PD-L axis

Bestimmung der PD-L1-Expression auf CTCs von NSCLC-Patienten und Korrelation mit dem Therapieansprechen auf PD-(L)1-Inhibitoren

Amaryllidaceae alkaloids with anti-Trypanosoma cruzi activity

NK cell transfer overcomes resistance to PD-(L)1 therapy in aged mice

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Role of the PD-1/PD-L inhibitory pathway during experimental infection by Trypanosoma cruzi Tulahuen strain

Object Details

Classification and Topics

Contributors, Places and Time

Further information

Data provider

Associated

Time of origin

Other Objects (12)

PD-1/PD-L blockade in gastrointestinal cancers: lessons learned and the road toward precision immunotherapy

Clathrin expression in Trypanosoma cruzi

Combined use of tyrosine kinase inhibitors with PD-(L)1 blockade increased the risk of thyroid dysfunction in PD-(L)1 blockade: a prospective study

The PD-1/PD-L1 Inhibitory Pathway is Altered in Primary Glomerulonephritides

Plant Metabolites Active against Trypanosoma cruzi

First-line hepatic arterial infusion chemotherapy plus lenvatinib and PD-(L)1 inhibitors versus systemic chemotherapy alone or with PD-(L)1 inhibitors in unresectable intrahepatic cholangiocarcinoma

WNT/β-catenin regulatory roles on PD-(L)1 and immunotherapy responses

CTLA4 blockade abrogates KEAP1/STK11-related resistance to PD-(L)1 inhibitors

Immune response in breast cancer brain metastases and their microenvironment: the role of the PD-1/PD-L axis

Bestimmung der PD-L1-Expression auf CTCs von NSCLC-Patienten und Korrelation mit dem Therapieansprechen auf PD-(L)1-Inhibitoren

Amaryllidaceae alkaloids with anti-Trypanosoma cruzi activity

NK cell transfer overcomes resistance to PD-(L)1 therapy in aged mice

PD-1/PD-L blockade in gastrointestinal cancers: lessons learned and the road toward precision immunotherapy

Clathrin expression in Trypanosoma cruzi

Combined use of tyrosine kinase inhibitors with PD-(L)1 blockade increased the risk of thyroid dysfunction in PD-(L)1 blockade: a prospective study

The PD-1/PD-L1 Inhibitory Pathway is Altered in Primary Glomerulonephritides

Plant Metabolites Active against Trypanosoma cruzi

First-line hepatic arterial infusion chemotherapy plus lenvatinib and PD-(L)1 inhibitors versus systemic chemotherapy alone or with PD-(L)1 inhibitors in unresectable intrahepatic cholangiocarcinoma

WNT/β-catenin regulatory roles on PD-(L)1 and immunotherapy responses

CTLA4 blockade abrogates KEAP1/STK11-related resistance to PD-(L)1 inhibitors

Immune response in breast cancer brain metastases and their microenvironment: the role of the PD-1/PD-L axis

Bestimmung der PD-L1-Expression auf CTCs von NSCLC-Patienten und Korrelation mit dem Therapieansprechen auf PD-(L)1-Inhibitoren

Amaryllidaceae alkaloids with anti-Trypanosoma cruzi activity

NK cell transfer overcomes resistance to PD-(L)1 therapy in aged mice

PD-1/PD-L blockade in gastrointestinal cancers: lessons learned and the road toward precision immunotherapy

Clathrin expression in Trypanosoma cruzi

Combined use of tyrosine kinase inhibitors with PD-(L)1 blockade increased the risk of thyroid dysfunction in PD-(L)1 blockade: a prospective study

The PD-1/PD-L1 Inhibitory Pathway is Altered in Primary Glomerulonephritides

Plant Metabolites Active against Trypanosoma cruzi

First-line hepatic arterial infusion chemotherapy plus lenvatinib and PD-(L)1 inhibitors versus systemic chemotherapy alone or with PD-(L)1 inhibitors in unresectable intrahepatic cholangiocarcinoma

WNT/β-catenin regulatory roles on PD-(L)1 and immunotherapy responses

CTLA4 blockade abrogates KEAP1/STK11-related resistance to PD-(L)1 inhibitors

Immune response in breast cancer brain metastases and their microenvironment: the role of the PD-1/PD-L axis

Bestimmung der PD-L1-Expression auf CTCs von NSCLC-Patienten und Korrelation mit dem Therapieansprechen auf PD-(L)1-Inhibitoren

Amaryllidaceae alkaloids with anti-Trypanosoma cruzi activity

NK cell transfer overcomes resistance to PD-(L)1 therapy in aged mice

Related objects

Reset password